OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role and Mechanism of Gut Microbiota in Human Disease
Yinwei Chen, Jinghua Zhou, Li Wang
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 423

Showing 1-25 of 423 citing articles:

Microbiota medicine: towards clinical revolution
Prisca Gebrayel, Carole Nicco, Souhaila Al Khodor, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 191

Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
Jody Rusch, Brian T. Layden, Lara R. Dugas
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 93

Possible Side Effects of Polyphenols and Their Interactions with Medicines
Aleksandra Duda‐Chodak, Tomasz Tarko
Molecules (2023) Vol. 28, Iss. 6, pp. 2536-2536
Open Access | Times Cited: 89

Genetic correlations between Alzheimer’s disease and gut microbiome genera
Davis Cammann, Yimei Lu, Melika J. Cummings, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 84

The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life
Sarusha Santhiravel, Alaa El‐Din A. Bekhit, Eresha Mendis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8124-8124
Open Access | Times Cited: 72

Current understanding of antibiotic-associated dysbiosis and approaches for its management
Dhanasekhar Kesavelu, Pramod Jog
Therapeutic Advances in Infectious Disease (2023) Vol. 10
Open Access | Times Cited: 60

Intestinal and fecal pH in human health
Ryodai Yamamura, Kumi Y. Inoue, Kunihiko Nishino, et al.
Frontiers in Microbiomes (2023) Vol. 2
Open Access | Times Cited: 55

Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3010-3010
Open Access | Times Cited: 17

Human milk oligosaccharides: bridging the gap in intestinal microbiota between mothers and infants
Wen Sun, Lin Tao, Chen Qian, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1

Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 1

Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Guilherme Ramos Meyers, Hanen Samouda, Torsten Bohn
Nutrients (2022) Vol. 14, Iss. 24, pp. 5361-5361
Open Access | Times Cited: 57

Correlation between human gut microbiome and diseases
Barkha Madhogaria, Priyanka Bhowmik, Atreyee Kundu
Infectious Medicine (2022) Vol. 1, Iss. 3, pp. 180-191
Open Access | Times Cited: 49

Differences in kinetics and dynamics of endogenous versus exogenous advanced glycation end products (AGEs) and their precursors
Katja C.W. van Dongen, Leonie Kappetein, Ignacio Miro Estruch, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 112987-112987
Open Access | Times Cited: 40

Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases
Silvia Vivarelli, Chiara Costa, Michele Teodoro, et al.
Archives of Toxicology (2022) Vol. 97, Iss. 1, pp. 3-38
Closed Access | Times Cited: 38

Fructus mori polysaccharide alleviates diabetic symptoms by regulating intestinal microbiota and intestinal barrier against TLR4/NF-κB pathway
Xiaoxia Chen, Junlin Wu, Xiong Fu, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 126038-126038
Closed Access | Times Cited: 36

Modulation of the Gut Microbiota with Prebiotics and Antimicrobial Agents from Pleurotus ostreatus Mushroom
Gréta Törős, Hassan El-Ramady, József Prokisch, et al.
Foods (2023) Vol. 12, Iss. 10, pp. 2010-2010
Open Access | Times Cited: 34

Fibromyalgia and Irritable Bowel Syndrome Interaction: A Possible Role for Gut Microbiota and Gut-Brain Axis
Cinzia Garofalo, Costanza Maria Cristiani, Sara Ilari, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1701-1701
Open Access | Times Cited: 25

The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 25

Immunomodulatory Properties of Probiotics and Their Derived Bioactive Compounds
Christina Thoda, Maria Touraki
Applied Sciences (2023) Vol. 13, Iss. 8, pp. 4726-4726
Open Access | Times Cited: 24

The Impact of Smoking on Microbiota: A Narrative Review
Sara Cicchinelli, Federico Rosa, Federica Manca, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1144-1144
Open Access | Times Cited: 24

Gut microbiota and chronic obstructive pulmonary disease: a Mendelian randomization study
Yi Wei, Xuechao Lu, Chao Liu
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 24

Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO
Ruxin Tu, Jian Xia
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 1, pp. 102-121
Closed Access | Times Cited: 22

Page 1 - Next Page

Scroll to top